Skip to main content
. 2002 Dec 26;2:37. doi: 10.1186/1471-2407-2-37

Table 14.

Estimated global and regional number of new cases and age-standardised incidence rate of cancer by site, males, 2000

WHO sub region

World AFRO AMRO EMRO EURO SEARO WPRO






Site D E A B D B D A B1 B2 C B D A B1 B2 B3
Number of new cases (000s)
Mouth and oropharynx cancers 267.1 12.1 16.5 11.3 10.4 0.9 2.6 1.7 28.7 7.4 0.9 17.8 16.0 98.1 6.5 29.7 6.1 0.5
Oesophagus cancer 286.5 5.1 14.1 12.4 11.1 0.7 1.9 0.8 22.8 3.6 1.8 10.7 3.8 42.0 10.1 142.7 3.0 0.0
Stomach cancer 589.3 13.3 10.9 11.8 29.7 8.7 8.6 2.5 45.6 17.2 4.0 48.6 8.6 30.1 40.6 300.9 7.6 0.1
Colon and rectum cancers 527.8 9.5 12.0 85.6 21.2 2.2 3.2 3.1 133.8 21.5 1.4 42.8 21.4 25.7 49.2 91.0 3.8 0.1
Liver cancer 422.0 20.0 23.6 9.0 9.5 2.9 3.1 2.3 26.1 6.0 0.7 7.9 28.6 18.4 24.6 232.8 6.2 0.2
Pancreas cancer 119.3 1.5 2.8 16.5 8.1 1.2 0.9 1.0 27.4 5.9 1.0 11.4 3.7 7.3 11.5 18.7 0.5 0.0
Trachea, bronchus, lung cancers 939.9 7.4 9.8 112.1 38.5 1.7 9.3 7.4 172.0 49.5 3.9 89.3 43.1 107.8 46.9 227.8 13.1 0.3
Melanoma of the skin 118.2 3.5 3.4 61.8 5.3 0.9 0.3 0.2 22.6 3.2 0.3 4.0 1.2 2.1 6.7 2.6 0.1 0.1
Breast cancer 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Cervix uteri cancer 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Corpus uteri cancer 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Ovary cancer 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Prostate cancer 550.2 36.5 28.2 165.7 46.0 8.6 3.2 2.7 139.1 15.2 0.8 22.3 13.4 29.6 28.1 9.5 1.2 0.0
Bladder cancer 277.2 10.6 7.3 60.3 8.1 0.8 4.1 14.4 65.1 12.1 1.2 17.8 7.7 27.8 13.5 24.8 1.5 0.0
Lymphomas, multiple myeloma 238.5 20.3 18.6 36.2 13.4 2.8 6.5 5.2 39.3 7.8 1.3 7.4 13.3 36.5 11.8 15.2 2.6 0.2
Leukaemia 195.2 6.3 9.2 20.6 13.1 2.9 3.4 5.3 25.6 6.6 1.1 9.3 10.7 28.2 6.7 44.0 2.2 0.1
Other malignant neoplasms 635.8 24.2 33.5 84.8 54.2 8.6 10.3 6.2 128.4 32.5 4.7 56.3 24.2 77.8 35.8 47.7 6.4 0.3

Age-standardised incidence rate per 100,000
Mouth and oropharynx cancers 8.8 12.9 18.4 5.0 5.5 3.3 4.9 3.6 8.6 7.4 4.5 10.9 9.3 18.5 4.7 3.9 12.0 21.7
Oesophagus cancer 9.4 5.7 16.8 5.1 5.9 3.1 3.8 1.7 6.0 3.4 9.4 6.3 2.2 8.2 6.6 19.2 6.3 2.0
Stomach cancer 19.4 15.0 13.0 4.6 15.8 35.8 17.4 5.5 11.0 16.4 21.3 28.8 5.2 5.9 25.6 40.8 15.9 3.8
Colon and rectum cancers 17.3 10.4 14.6 34.4 11.3 9.2 6.3 6.5 33.0 20.4 7.1 25.1 12.9 4.9 32.4 12.3 7.8 5.8
Liver cancer 13.7 20.3 24.7 3.7 5.0 11.4 6.4 5.0 6.4 5.7 3.6 4.8 16.0 3.2 16.2 30.8 12.1 9.9
Pancreas cancer 3.9 1.6 3.5 6.5 4.3 4.8 1.8 2.3 6.8 5.7 5.3 6.8 2.2 1.5 7.3 2.5 1.0 0.2
Trachea, bronchus, lung cancers 30.9 8.3 12.0 44.8 20.6 6.9 18.9 16.6 43.3 47.1 20.6 52.2 27.5 20.3 28.9 30.8 26.4 14.7
Melanoma of the skin 3.9 3.8 3.7 27.2 2.8 3.7 0.6 0.3 6.6 3.1 1.6 2.6 0.7 0.4 4.9 0.3 0.3 3.6
Breast cancer 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Cervix uteri cancer 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Corpus uteri cancer 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Ovary cancer 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Prostate cancer 18.0 45.0 38.9 63.7 24.8 36.3 6.9 6.5 31.8 14.1 4.4 12.8 8.6 5.8 17.1 1.3 2.5 2.3
Bladder cancer 9.0 12.0 8.8 24.4 4.3 3.3 8.5 30.5 16.1 11.6 6.4 10.7 4.6 4.8 8.7 3.5 3.1 1.4
Lymphomas, multiple myeloma 7.8 18.2 17.0 15.3 6.8 10.7 10.6 8.6 10.9 8.1 6.2 5.1 7.6 6.1 8.2 2.1 4.5 7.1
Leukaemia 6.4 5.5 7.7 8.9 6.3 8.6 5.1 7.8 7.5 7.2 4.3 6.8 5.7 4.3 5.8 6.7 3.3 3.3
Other malignant neoplasms 20.8 24.1 37.1 39.9 27.2 31.0 19.1 11.3 39.1 32.8 22.4 37.5 13.5 13.7 27.0 6.6 12.4 11.2